According to the Enterprise Research App, recently, the Asia-Pacific pharmaceutical industry underwent commercial and commercial changes, and the registered capital increased from 600 million yuan to 740 million yuan. According to enterprise investigation information, the company was founded in December 2001, and the legal representative is Cen Jianwei. The business scope includes: pharmaceutical production; pharmaceutical import and export; pharmaceutical Internet information services, etc. The company is jointly owned by Ningbo Fubang Holding Group Co., Ltd. and Zhejiang Asia Pacific Group Co., Ltd.

Zhitongcaijing · 06/04 06:09
According to the Enterprise Research App, recently, the Asia-Pacific pharmaceutical industry underwent commercial and commercial changes, and the registered capital increased from 600 million yuan to 740 million yuan. According to enterprise investigation information, the company was founded in December 2001, and the legal representative is Cen Jianwei. The business scope includes: pharmaceutical production; pharmaceutical import and export; pharmaceutical Internet information services, etc. The company is jointly owned by Ningbo Fubang Holding Group Co., Ltd. and Zhejiang Asia Pacific Group Co., Ltd.